BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12180285)

  • 1. [The role of liver biopsy in the management of chronic hepatitis C].
    Nousbaum JB
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B168-79. PubMed ID: 12180285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C in certain patient populations: children, patients with hemophilia and thalassemia, the hemodialyzed and kidney transplant recipients].
    Fontaine H
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B91-104. PubMed ID: 12180314
    [No Abstract]   [Full Text] [Related]  

  • 3. Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
    Perez RM; Ferreira AS; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    Clin Transplant; 2005 Oct; 19(5):622-5. PubMed ID: 16146553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C.
    Theodore D; Fried MW; Kleiner DE; Kroner BL; Goedert JJ; Eyster ME; Faust SP; Sherman KE; Kessler CM; Francis C; Aledort LM
    Haemophilia; 2004 Sep; 10(5):413-21. PubMed ID: 15357765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre study of the usefulness of liver biopsy in hepatitis C.
    Bain VG; Bonacini M; Govindarajan S; Ma M; Sherman M; Gibas A; Cotler SJ; Deschenes M; Kaita K; Jhangri GS
    J Viral Hepat; 2004 Jul; 11(4):375-82. PubMed ID: 15230861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatitis C virus-related cirrhosis].
    Bronowicki JP
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B220-4. PubMed ID: 12180292
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease.
    Pawa S; Ehrinpreis M; Mutchnick M; Janisse J; Dhar R; Siddiqui FA
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1316-20. PubMed ID: 17904916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
    Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
    Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
    [No Abstract]   [Full Text] [Related]  

  • 11. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
    Sebastiani G; Vario A; Guido M; Noventa F; Plebani M; Pistis R; Ferrari A; Alberti A
    J Hepatol; 2006 Apr; 44(4):686-93. PubMed ID: 16490278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease.
    Gómez-Domínguez E; Mendoza J; Rubio S; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R
    Aliment Pharmacol Ther; 2006 Aug; 24(3):513-8. PubMed ID: 16886917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
    Ziol M; Handra-Luca A; Kettaneh A; Christidis C; Mal F; Kazemi F; de Lédinghen V; Marcellin P; Dhumeaux D; Trinchet JC; Beaugrand M
    Hepatology; 2005 Jan; 41(1):48-54. PubMed ID: 15690481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
    Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
    J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease.
    Sterling RK; Lyons CD; Stravitz RT; Luketic VA; Sanyal AJ; Carr ME; Smith TJ; Hackney MH; Contos MJ; Mills SA; Kuhn JG; Nolte ME; Shiffman ML
    Haemophilia; 2007 Mar; 13(2):164-71. PubMed ID: 17286769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
    J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.
    Kyrlagkitsis I; Portmann B; Smith H; O'Grady J; Cramp ME
    Am J Gastroenterol; 2003 Jul; 98(7):1588-93. PubMed ID: 12873583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.